Efficacy and safety of inorganic nitrate/nitrite supplementary therapy in heart failure with preserved ejection fraction
BackgroundApproximately half of patients with heart failure have a preserved ejection fraction (HFpEF). To date, only SGLT-2i, ARNi, and MRAs treatments have been shown to be effective for HFpEF. Exercise intolerance is the primary clinical feature of HFpEF. The aim of this meta-analysis was to expl...
| 發表在: | Frontiers in Cardiovascular Medicine |
|---|---|
| Main Authors: | Feng Lv, Junyi Zhang, Yuan Tao |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2023-02-01
|
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1054666/full |
相似書籍
Heart Failure With Preserved Ejection Fraction and Obesity
由: Arjun Sinha, MD, et al.
出版: (2020-01-01)
由: Arjun Sinha, MD, et al.
出版: (2020-01-01)
Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder
由: Rahul N. Patel, et al.
出版: (2023-12-01)
由: Rahul N. Patel, et al.
出版: (2023-12-01)
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy
由: Natasha L. Patel‐Murray, et al.
出版: (2024-07-01)
由: Natasha L. Patel‐Murray, et al.
出版: (2024-07-01)
Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose
由: Janet D. Pierce, et al.
出版: (2018-04-01)
由: Janet D. Pierce, et al.
出版: (2018-04-01)
Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey
由: Magdy Abdelhamid, et al.
出版: (2023-10-01)
由: Magdy Abdelhamid, et al.
出版: (2023-10-01)
Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction
由: Hao Chen, et al.
出版: (2022-10-01)
由: Hao Chen, et al.
出版: (2022-10-01)
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
由: Paolo Morfino, et al.
出版: (2022-08-01)
由: Paolo Morfino, et al.
出版: (2022-08-01)
Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
由: Satyam Sarma, et al.
出版: (2020-11-01)
由: Satyam Sarma, et al.
出版: (2020-11-01)
The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
由: Becker Al-Khayatt, et al.
出版: (2024-05-01)
由: Becker Al-Khayatt, et al.
出版: (2024-05-01)
Circulating Monocyte Count as a Surrogate Marker for Ventricular-Arterial Remodeling and Incident Heart Failure with Preserved Ejection Fraction
由: Kuang-Te Wang, et al.
出版: (2020-05-01)
由: Kuang-Te Wang, et al.
出版: (2020-05-01)
Heart failure outcomes by left ventricular ejection fraction in a contemporary region‐wide patient cohort
由: Johan Sundström, et al.
出版: (2024-06-01)
由: Johan Sundström, et al.
出版: (2024-06-01)
Aortic thoracic neuromodulation in heart failure with preserved ejection fraction
由: Pasquale Paolisso, et al.
出版: (2023-02-01)
由: Pasquale Paolisso, et al.
出版: (2023-02-01)
The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
由: Clement Lau, et al.
出版: (2022-07-01)
由: Clement Lau, et al.
出版: (2022-07-01)
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility
由: Michael Chhor, et al.
出版: (2023-02-01)
由: Michael Chhor, et al.
出版: (2023-02-01)
Heart failure with preserved ejection fraction update: A review of clinical trials and new therapeutic considerations
由: Andrii Maryniak, et al.
出版: (2022-07-01)
由: Andrii Maryniak, et al.
出版: (2022-07-01)
Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
由: Bin Dong, et al.
出版: (2022-11-01)
由: Bin Dong, et al.
出版: (2022-11-01)
miRNA-Orchestrated Fibroinflammatory Responses in Heart Failure with Preserved Ejection Fraction: Translational Opportunities for Precision Medicine
由: Maria Andreea Micu, et al.
出版: (2025-09-01)
由: Maria Andreea Micu, et al.
出版: (2025-09-01)
Screening of biomarkers for diagnosing chronic kidney disease and heart failure with preserved ejection fraction through bioinformatics analysis
由: Can Hou, et al.
出版: (2025-03-01)
由: Can Hou, et al.
出版: (2025-03-01)
Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease
由: Noah Todd, et al.
出版: (2020-10-01)
由: Noah Todd, et al.
出版: (2020-10-01)
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP‐HF registry
由: Matteo Pagnesi, et al.
出版: (2024-02-01)
由: Matteo Pagnesi, et al.
出版: (2024-02-01)
Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study
由: Jerremy Weerts, et al.
出版: (2025-07-01)
由: Jerremy Weerts, et al.
出版: (2025-07-01)
Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction
由: Petra Büttner, et al.
出版: (2025-04-01)
由: Petra Büttner, et al.
出版: (2025-04-01)
Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
由: Chen Chi, et al.
出版: (2021-08-01)
由: Chen Chi, et al.
出版: (2021-08-01)
Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
由: Yohei Sotomi, et al.
出版: (2021-06-01)
由: Yohei Sotomi, et al.
出版: (2021-06-01)
A Review of Contemporary and Future Pharmacotherapy for Chronic Heart Failure in Children
由: Bibhuti B. Das
出版: (2024-07-01)
由: Bibhuti B. Das
出版: (2024-07-01)
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
由: Elisabeth A. Jalink, et al.
出版: (2024-01-01)
由: Elisabeth A. Jalink, et al.
出版: (2024-01-01)
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?
由: Paschalis Karakasis, et al.
出版: (2024-09-01)
由: Paschalis Karakasis, et al.
出版: (2024-09-01)
Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism
由: Payman Zamani, et al.
出版: (2021-08-01)
由: Payman Zamani, et al.
出版: (2021-08-01)
Heart failure with preserved ejection fraction and atrial fibrillation: clinical management in the context of recent therapeutic advances in heart failure and electrophysiology
由: Eunice Yang, et al.
出版: (2024-01-01)
由: Eunice Yang, et al.
出版: (2024-01-01)
Heart Failure with Preserved Ejection Fraction (HFpEF): Part 2 Review of Experience and Evidence with SGLT-2 Inhibitors and Commentary
由: Soneil Guptha, Eteri Tsetskhladze
出版: (2023-06-01)
由: Soneil Guptha, Eteri Tsetskhladze
出版: (2023-06-01)
Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment
由: Era Gorica, et al.
出版: (2025-07-01)
由: Era Gorica, et al.
出版: (2025-07-01)
Effects of exercise training on cardiac output in subjects with heart failure with preserved ejection fraction (HFpEF) — a protocol for a systematic review and meta-analysis
由: Raphael Schoch, et al.
出版: (2024-06-01)
由: Raphael Schoch, et al.
出版: (2024-06-01)
Cardiopulmonary exercise testing as a prognosis‐assessing tool in heart failure with preserved ejection fraction
由: C. Rozados daConceicao, et al.
出版: (2025-06-01)
由: C. Rozados daConceicao, et al.
出版: (2025-06-01)
Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study
由: Ravi V. Shah, et al.
出版: (2023-11-01)
由: Ravi V. Shah, et al.
出版: (2023-11-01)
Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
由: José M. Inácio, et al.
出版: (2023-07-01)
由: José M. Inácio, et al.
出版: (2023-07-01)
Long-term prognostic value of CRP–albumin–lymphocyte index in elderly patients with heart failure with preserved ejection fraction
由: Qingwei He, et al.
出版: (2025-06-01)
由: Qingwei He, et al.
出版: (2025-06-01)
Heart Failure with Preserved Ejection Fraction (HFpEF): Part 1 Review of Experience and Evidence in PARAGON-HF with Commentary
由: Soneil Guptha; Eteri Tsetskhladze
出版: (2023-07-01)
由: Soneil Guptha; Eteri Tsetskhladze
出版: (2023-07-01)
Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
由: Kramer J. Wahlberg, et al.
出版: (2024-01-01)
由: Kramer J. Wahlberg, et al.
出版: (2024-01-01)
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
由: Alberto Palazzuoli, et al.
出版: (2023-01-01)
由: Alberto Palazzuoli, et al.
出版: (2023-01-01)
Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study
由: Rui Valdiviesso, et al.
出版: (2023-12-01)
由: Rui Valdiviesso, et al.
出版: (2023-12-01)
相似書籍
-
Heart Failure With Preserved Ejection Fraction and Obesity
由: Arjun Sinha, MD, et al.
出版: (2020-01-01) -
Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder
由: Rahul N. Patel, et al.
出版: (2023-12-01) -
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy
由: Natasha L. Patel‐Murray, et al.
出版: (2024-07-01) -
Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose
由: Janet D. Pierce, et al.
出版: (2018-04-01) -
Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey
由: Magdy Abdelhamid, et al.
出版: (2023-10-01)